Intracranial Aneurysm Market Report 2026

The intracranial aneurysm market size has grown rapidly in recent years. It will grow from $1.82 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing incidence of hypertension-related cerebrovascular disorders, advancements in neuroimaging technologies, limitations of conventional open brain surgeries, rising awareness of aneurysm rupture risks, expansion of neurosurgical and neurointerventional infrastructure.

The intracranial aneurysm market size is expected to see rapid growth in the next few years. It will grow to $3.04 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to growing aging population, increasing adoption of flow diverter devices, rising demand for early aneurysm screening, technological advancements in embolization devices, expanding investment in neurovascular research and innovation. Major trends in the forecast period include increasing preference for minimally invasive aneurysm treatments, rising adoption of endovascular coiling and flow diversion, growing focus on early detection and preventive intervention, expansion of advanced neurovascular treatment centers, improved clinical outcomes through multidisciplinary care.

The growing demand for minimally invasive procedures is anticipated to drive the expansion of the intracranial aneurysm market. Minimally invasive procedures are medical interventions performed through small incisions or openings, minimizing patient trauma and recovery time. This increasing demand is attributed to their ability to provide shorter recovery periods, lower risks of complications, less pain, and smaller scars, making them more attractive to patients seeking faster and safer treatment options. Management of intracranial aneurysms has transformed minimally invasive procedures by allowing precise, targeted interventions that shorten patient recovery time and improve overall surgical outcomes. For example, in August 2023, according to The Aesthetic Society, a US-based organization focused on plastic surgery and cosmetic medicine, Americans spent over $11.8 billion on aesthetic procedures in 2023, representing a 2% rise compared to the previous year. Additionally, in 2023, the American Society of Plastic Surgeons, a US-based specialty organization, reported that the total number of cosmetic minimally invasive procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Consequently, the increasing demand for minimally invasive procedures is expected to propel the growth of the intracranial aneurysm market.

Major companies in the intracranial aneurysm sector are concentrating on developing advanced solutions, such as next-generation flow diverters, to enhance device functionality, improve vessel-wall apposition, and simplify deployment during endovascular procedures. A flow diverter is an implantable neurovascular device intended to redirect blood flow away from aneurysm sacs, promoting healing, particularly in wide-neck or complex intracranial aneurysms. For example, in July 2025, Stryker Corporation, a U.S.-based medical technology company, introduced the Surpass Elite Flow Diverter in the United States, South Korea, and Europe. Designed with an upgraded implant architecture featuring a higher braid angle and optimized heat treatment, the device provides improved opening, enhanced vessel-wall apposition, and minimized manipulation during deployment. It also incorporates the BioStealth Surface, a proprietary thromboresistant surface modification created through a neutralization process, aimed at reducing thrombin generation and enabling safer, more efficient flow-diversion procedures in complex aneurysm cases.

In May 2023, Stryker Corporation, a U.S.-based medical technology company, acquired Cerus Endovascular Limited for an undisclosed amount. Through this acquisition, Stryker Corporation aims to strengthen its portfolio of neurointerventional devices for treating intracranial aneurysms, particularly by incorporating Cerus's CE-marked products such as the Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter, which cater to the increasing demand for one-and-done intrasaccular aneurysm therapy. Cerus Endovascular Limited is a U.S.-based company that develops innovative medical devices for the treatment of intracranial aneurysms.

Major companies operating in the intracranial aneurysm market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, Phenox GmbH, Balt Group, Acandis GmbH & Co. KG, Codman Neuro, EndoStream Medical Ltd., Shape Memory Medical Inc., Evasc Neurovascular Enterprises ULC.

North America was the largest region in the intracranial aneurysm market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intracranial aneurysm market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intracranial aneurysm market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the intracranial aneurysm market by increasing costs of imported neurovascular devices, embolization materials, and precision-manufactured access tools. These impacts are most evident in flow diverters, coils, and aspiration device segments, particularly across asia-pacific and europe where device sourcing is globally distributed. Higher tariffs have raised procurement and procedural costs for hospitals and specialty clinics. However, tariffs are also encouraging domestic manufacturing, regional supplier development, and innovation in cost-optimized aneurysm treatment devices, supporting long-term market resilience.

The intracranial aneurysm market research report is one of a series of new reports that provides intracranial aneurysm market statistics, including intracranial aneurysm industry global market size, regional shares, competitors with a intracranial aneurysm market share, detailed intracranial aneurysm market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial aneurysm industry. This intracranial aneurysm market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An intracranial aneurysm is a localized, abnormal bulging or dilation of a blood vessel within the brain. It occurs when a blood vessel in the brain becomes weakened, often due to a combination of genetic predisposition, high blood pressure, and other risk factors such as smoking or aging.

The primary treatment approaches for intracranial aneurysms include endovascular coiling, surgical clipping, flow diverters, and other methods. Endovascular coiling is a minimally invasive procedure used to manage intracranial aneurysms. The different product categories include aneurysm therapeutic devices, embolization devices, aspiration devices, and access devices, which are utilized by various end users such as hospitals, specialty clinics, and others.

The intracranial aneurysm market consists of sales of flow diverter devices, embolization coils, neurovascular stents, intracranial balloons, aneurysm clips, and monitoring systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.